About Us
History
Core Values
Team
Investment Focus
Laboratory Products
Laboratory Services
Contract Manufacturing
Pharma Services
Specialty Pharma
Working With Us
Portfolio
News
Contact
✕
News
January 10, 2022
January 10, 2022
Ampersand Announces Sale of Nexelis
January 5, 2022
January 5, 2022
Confluent Medical Announces Significant Strategic Investment From TPG
December 20, 2021
December 20, 2021
Ampersand Completes Sale of Adaptas Solutions to IMI plc
December 15, 2021
December 15, 2021
Alcami Announces the Acquisition of Masy BioServices
December 1, 2021
December 1, 2021
Martijn G. Mulder: In Memoriam
November 22, 2021
November 22, 2021
ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Scale of Generics and CDMO Businesses
November 18, 2021
November 18, 2021
Ampersand Invests in Alliance Pharma, Leading Bioanalytical CRO
November 17, 2021
November 17, 2021
Leinco Technologies Receives Growth Equity Investment From Ampersand Capital Partners
November 15, 2021
November 15, 2021
Proposed acquisition of Life Sciences manufacturer Adaptas Solutions for $271m
November 1, 2021
November 1, 2021
ANI Pharmaceuticals Announces FDA Approval of Purified Cortrophin™ Gel for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis and Nephrotic Syndrome
Prev page
1
...
3
4
5
6
7
...
20
Next page